drugset / Trial / NCT07382453

Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases

NCT07382453

Phase 2 Not yet recruiting 30 enrolled Affiliated Hospital of Nantong University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether poly(β-amino ester)(PAE)hydrogel loaded with tRNA-derived fragments-antisense oligonucleotides-exosomes(tRF-ASO-Exo) could alleviate symptoms in patients with diabetic ocular surface diseases(DOSD).

Timeline

Start
2026-02-15
Primary completion
2028-12-30
Completion
2029-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Exosomes Other / unclassified 10 ug
Subject tRF-ASO-Exo Unknown 10 ug
Subject tRF-ASO-Exo-PAE Unknown 10 ug Topical

Indications